February 13, 2021
Vivos Therapeutics Launches VivoScore Diagnostic Technology
Vivos Therapeutics Launches VivoScore Diagnostic Technology for Home Sleep Apnea Testing in Children and Adults…
February 13, 2021
Vivos Therapeutics Launches AireO2 Patient Management Technology
Vivos Therapeutics Launches AireO2 Patient Management Technology to Treat Patients with Obstructive Sleep Apnea Obstructive…
February 13, 2021
Vivos Therapeutics Announces Closing of Initial Public Offering
Vivos Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’…
December 15, 2020
Vivos Therapeutics Submits FDA 510(k) Application for the Vivos mmRNA Oral Appliance
If Approved for Clearance, Vivos’ Updated Device Will Treat Mild to Moderate Sleep Apnea and…
